EVALUATION OF THE ROLE OF FECAL CALPROTECTIN AS A BIOMARKER OF ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH CROHN’S DISEASE . Glob. j. public health med. [Internet]. 2026 Sep. 22 [cited 2026 Sep. 22];8(1 (Ongoing):216-27. Available from: https://www.gjphm.org/index.php/gjphm/article/view/410